本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atea Pharmaceuticals, Inc.

3.15
-0.0400-1.25%
盤後3.12-0.0300-0.95%16:10 EST
成交量:23.28萬
成交額:73.83萬
市值:2.46億
市盈率:-1.78
高:3.23
開:3.19
低:3.14
收:3.19
52周最高:4.02
52周最低:2.46
股本:7,812.68萬
流通股本:6,000.97萬
量比:0.74
換手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-1.7696
每股收益(LYR):-1.9983
淨資產收益率:-37.98%
總資產收益率:-23.86%
市淨率:0.78
市盈率(LYR):-1.58

資料載入中...

2021/04/19

重要事件披露

8-K - Current report
2021/04/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/05

重要事件披露

8-K - Current report
2020/10/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/29

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/23

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/09

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933